(Updates with Indonesia, Philippines, Moldova, Bangladesh, Nigeria, Bahamas, Belize)
(Reuters) – The COVAX facility, backed by the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 177 million COVID-19 vaccine doses to 138 countries so far according to GAVI data, falling short of its target to secure 2 billion doses for lower-income countries by the end of 2021.
The following tables list countries that have received vaccines under the scheme, sorted by region and latest delivery:
AFRICA & MIDDLE EAST
COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL
DELIVERY DELIVERED
Ivory Coast 504,000 Feb. 26 AstraZeneca/Oxford 26 million 504,000
Democratic 1.7 million March 2 AstraZeneca/Oxford 87 million 1.7 million
Republic of Congo
Sudan 828,000 March 3 AstraZeneca/Oxford 43 million 828,000
Sao Tome and 24,000 March 3 AstraZeneca/Oxford 215,000 24,000
Principe
Mali 396,000 March 4 AstraZeneca/Oxford 20 million 396,000
Sierra Leone 96,000 March 8 AstraZeneca/Oxford 7.8 million 96,000
Cape Verde 24,000 March 12 AstraZeneca/Oxford 540,000 24,000
Somalia 300,000 March 15 AstraZeneca/Oxford 15 million 300,000
Lebanon 33,600 March 24 AstraZeneca/Oxford 6.9 million 33,600
South Sudan 132,000 March 25 AstraZeneca/Oxford 11 million 132,000
Iraq 336,000 March 25 AstraZeneca/Oxford 39 million 336,000
Yemen 360,000 March 31 AstraZeneca/Oxford 29 million 360,000
Algeria 364,800 April 3 AstraZeneca/Oxford 43 million 364,800
Guinea 194,400 April 11 AstraZeneca/Oxford 13 million 194,400
Comoros Islands 12,000 April 12 AstraZeneca/Oxford 851,000 12,000
Guinea-Bissau 28,800 April 13 AstraZeneca/Oxford 1.9 million 28,800
Syria 256,800 April 22 AstraZeneca/Oxford 17 million 256,800
Ghana 350,000 May 7 AstraZeneca/Oxford 30 million 950,000
Egypt 1.7 million May 13 AstraZeneca/Oxford 100 million 2.6 million
Namibia 43,000 May 24 AstraZeneca/Oxford 2.5 million 67,000
Palestinian 102,960 May 25 Pfizer/BioNTech 4.7 million 164,400
Territories
Rwanda 247,000 May 28 AstraZeneca/Oxford 13 million 589,960
Togo 50,310 May 29 Pfizer/BioNTech 8.1 million 206,310
Botswana 38,400 May 29 AstraZeneca/Oxford 2.3 million 38,400
Angola 100,620 June 1 Pfizer/BioNTech 32 million 724,620
Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800
Chad 100,620 June 23 Pfizer/BioNTech 15.9 million 100,620
Libya 54,600 June 24 Pfizer/BioNTech 6.8 million 229,800
Ethiopia 453,600 July 19 J&J 112 million 2.6 million
Djibouti 151,200 July 17 J&J 990,000 175,200
Senegal 151,200 July 21 J&J 16 million 659,200
Cameroon 303,050 July 21 J&J 25.9 million 694,250
Central African 302,400 July 22 J&J 4.7 million 302,400
Republic
Lesotho 302,400 July 23 J&J 2.1 million 374,400
Tanzania 1.0 million July 24 J&J 59.7 million 1.0 million
Malawi 192,000 July 24 AstraZeneca/Oxford 19 million 552,000
Morocco 302,400 July 25 J&J 36.9 million 302,400
Liberia 302,400 July 25 J&J 4.9 million 398,400
Benin 302,400 July 26 J&J 19 million 446,400
Mozambique 302,400 July 26 J&J 30 million 686,400
Madagascar 302,750 July 27 J&J 27 million 302,750
Eswatini 302,400 July 27 J&J 1.1 million 328,800
Zambia 151,200 July 28 J&J 18 million 758,400
Iran 1.0 million July 30 AstraZeneca/Oxford 83.9 million 2.5 million
Niger 151,200 July 30 J&J 23 million 657,400
Tunisia 1.0 million July 30 Moderna 12 million 1.9 million
Uganda 286,080 July 31 AstraZenecaOxford 44 million 1.2 million
Kenya 410,000 July 31 AstraZeneca/Oxford 53 million 1.6 million
South Africa 5.6 million July 31 Pfizer/BioNTech 58.6 million 5.6 million
Burkina Faso 151,200 August 1 J&J 20 million 417,400
Mauritania 302,400 August 1 J&J 4.5 million 403,100
Gambia 151,200 August 1 J&J 2.3 million 338,400
Nigeria 4.0 million August Moderna 201 million 7.9 million
2
EUROPE
COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL
DELIVERY DELIVERED
Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200
Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000
Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000
Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560
Serbia 120,000 May 12 AstraZeneca/Oxford 6.9 million 177,600
North 38,400 May 14 AstraZeneca/Oxford 2.1 million 62,400
Macedonia
Armenia 50,000 May 17 AstraZeneca/Oxford 3.0 million 74,000
Kosovo 100,620 May 27 Pfizer/BioNTech 1.8 million 163,020
Albania 40,800 June 2 AstraZeneca/Oxford 2.9 million 120,000
Ukraine 2.0 million July 18 Moderna 44 million 3.3 million
J&J
Moldova 301,000 August 1 2.7 million 644,000
ASIA & PACIFIC
COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL
DELIVERY DELIVERED
Maldives 12,000 March 7 AstraZeneca/Oxford 531,000 12,000
Afghanistan 468,000 March 8 AstraZeneca/Oxford 38 million 468,000
Tonga 24,000 March 31 AstraZeneca/Oxford 105,000 24,000
Nauru 7,200 April 2 AstraZeneca/Oxford 12,600 7,200
Brunei 24,000 April 2 AstraZeneca/Oxford 433,000 24,000
Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,600 4,800
Samoa 24,000 April 9 AstraZeneca/Oxford 197,000 24,000
Vanuatu 24,000 May 19 AstraZeneca/Oxford 300,000 24,000
Malaysia 559,200 May 21 AstraZeneca/Oxford 32 million 828,000
Mongolia 100,620 May 27 Pfizer/BioNTech 3.2 million 191,120
Timor-Leste 100,800 June 9 AstraZeneca/Oxford 1.3 million 124,800
Papua New 146,000 June 15 AstraZeneca/Oxford 8.8 million 278,000
Guinea
Solomon 28,800 June 19 AstraZeneca/Oxford 670,000 52,800
Islands
Nepal 1.5 July 12 J&J 29 million 1.8 million
million
Fiji 150,080 July 16 Moderna 900,000 196,080
Laos 1.0 July 19 J&J 7.2 million 1.2 million
million
Kiribati 24,000 July 25 AstraZeneca/Oxford 118,000 48,000
Tajikistan 1.5 July 25 Moderna 9.3 million 1.7 million
million
Pakistan 3.0 July 29 Moderna 217 million 8.5 million
million
Uzbekistan 3.0 July 29 Moderna 34 million 3.7 million
million
Sri Lanka 728,460 July 31 AstraZeneca/Oxford 22 million 2.4 million
Kyrgyzstan 226,500 July 31 AstraZeneca/Oxford 6.5 million 226,500
Moderna
Indonesia 3.5 August 1 271 million 19.2
million million
Cambodia 609,600 August 2 J&J 16 million 1.4 million
Vietnam 3.0 August 2 AstraZeneca/Oxford 96 million 8.6 million
million
Moderna
Philippines 3.0 August 3 108 million 13.2
million million
Bangladesh 616,780 August 3 AstraZeneca/Oxford 163 million 4.6 million
AMERICAS
COUNTRY LATEST DATE VACCINE TYPE POPULATION TOTAL
DELIVERY DELIVERED
Dominica 28,800 April 6 AstraZeneca/Oxford 72,000 28,800
Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600
Saint Kitts 21,600 April 7 AstraZeneca/Oxford 53,000 21,600
and Nevis
Argentina 864,000 April 18 AstraZeneca/Oxford 45 million 1,082,000
Guyana 38,400 May 10 AstraZeneca/Oxford 783,000 62,400
Trinidad and 33,600 May 10 AstraZeneca/Oxford 1.4 million 67,600
Tobago
Suriname 28,800 May 10 AstraZeneca/Oxford 581,000 52,800
Barbados 33,600 May 11 AstraZeneca/Oxford 287,000 67,200
Panama 74,400 May 11 AstraZeneca/Oxford 4.2 million 74,400
Saint Lucia 26,400 May 12 AstraZeneca/Oxford 183,000 50,400
Costa Rica 88,800 May 13 AstraZeneca/Oxford 5.0 million 132,000
Dominican 187,200 May 14 AstraZeneca/Oxford 10.7 million 278,400
Republic
Uruguay 50,400 May 14 AstraZeneca/Oxford 3.5 million 98,400
Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400
Saint 21,600 May 25 AstraZeneca/Oxford 111,000 45,600
Vincent and
the
Grenadines
Grenada 21,600 May 26 AstraZeneca/Oxford 112,000 45,600
Mexico 2.2 May 27 AstraZeneca/Oxford 128 million 3.3 million
million
Peru 511,200 May 29 AstraZeneca/Oxford 33 million 904,200
Jamaica 55,200 May 30 AstraZeneca/Oxford 2.9 million 124,800
Colombia 909,600 June 3 AstraZeneca/Oxford 50 million 3.3 million
Guatemala 321,600 June 3 AstraZeneca/Oxford 17 million 724,800
Paraguay 134,400 June 3 AstraZeneca/Oxford 7.0 million 304,400
Antigua and 16,800 June 9 AstraZeneca/Oxford 97,000 40,800
Barbuda
Ecuador 336,000 June 11 AstraZeneca/Oxford 17 million 756,000
Bolivia 1.0 July 11 J&J 12 million 1.4 million
million
Haiti 500,000 July 14 Moderna 11.2 million 500,000
Honduras 1.5 July 22 Moderna 9.7 million 3.4 million
million
El Salvador 1.5 July 22 Moderna 6.5 million 3.4 million
million
Brazil 441,600 July 30 AstraZeneca/Oxford 211 million 8.9 million
Nicaragua 36,480 July 30 AstraZeneca/Oxford 6.5 million 171,480
Bahamas 33,600 August 3 AstraZeneca/Oxford 390,000 67,200
Belize 33,600 August 3 AstraZeneca/Oxford 390,000 100,800
Sources: WHO, UNICEF, GAVI, releases from local authorities
(Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou in Gdansk; Editing by Emelia Sithole-Matarise, Giles Elgood, Mark Potter and Barbara Lewis)
